Hiroshi Tomita

Prof. Hiroshi Tomita

Iwate University, Morioka, Iwate, Japan
orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2001 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
Takanori YokotaTakanori Yokota
Takanori Yokota
KIKeiji Igarashi
Keiji Igarashi
TUToshiki Uchihara
Toshiki Uchihara
KJKou-Ichi Jishage
Kou-Ichi Jishage
Hiroshi TomitaHiroshi Tomita
Hiroshi Tomita
HAHiroyuki Arai
Hiroyuki Arai
α-Tocopherol transfer protein (α-TTP) maintains the concentration of serum α-tocopherol (vitamin E), one of the most potent fat-soluble antioxidants, by facilitating α-tocopherol export from the liver. Mutations of the α-TTP gene are linked to ataxia with isolated vitamin E deficiency (AVED). We produced a model mouse of AVED by deleting the α-TTP gene, which showed ataxia and retinal degeneration after 1 year of age. Because the brain α-TTP functions in maintaining α-tocopherol levels in the brain, α-tocopherol was completely depleted in the α-TTP −/− mouse brain, and the neurological phenotype of α-TTP −/− mice is much more severe than that of wild-type mice when maintained on an α-tocopherol-deficient diet. Lipid peroxidation in α-TTP −/− mice brains showed a significant increase, especially in degenerating neurons. α-Tocopherol supplementation suppressed lipid peroxidation and almost completely prevented the development of neurological symptoms. This therapy almost completely corrects the abnormalities in a mouse model of human neurodegenerative disease. Moreover, α-TTP −/− mice may prove to be excellent animal models of delayed onset, slowly progressive neuronal degeneration caused by chronic oxidative stress.

5 November 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Hiroshi TomitaHiroshi Tomita
Hiroshi Tomita
ESEriko Sugano
Eriko Sugano
YFYugo Fukazawa
Yugo Fukazawa
HIHitomi Isago
Hitomi Isago
YSYuka Sugiyama
Yuka Sugiyama
MTMakoto Tamai
Makoto Tamai
Channelrhodopsin-2 (ChR2), one of the archea-type rhodopsins from green algae, is a potentially useful optogenetic tool for restoring vision in patients with photoreceptor degeneration, such as retinitis pigmentosa. If the ChR2 gene is transferred to retinal ganglion cells (RGCs), which send visual information to the brain, the RGCs may be repurposed to act as photoreceptors. In this study, by using a transgenic rat expressing ChR2 specifically in the RGCs under the regulation of a Thy-1.2 promoter, we tested the possibility that direct photoactivation of RGCs could restore effective vision. Although the contrast sensitivities of the optomotor responses of transgenic rats were similar to those observed in the wild-type rats, they were enhanced for visual stimuli of low-spatial frequency after the degeneration of native photoreceptors. This result suggests that the visual signals derived from the ChR2-expressing RGCs were reinterpreted by the brain to form behavior-related vision.

1 February 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
HWHongxia Wang
Hongxia Wang
YSYuka Sugiyama
Yuka Sugiyama
THTakuya Hikima
Takuya Hikima
ESEriko Sugano
Eriko Sugano
Hiroshi TomitaHiroshi Tomita
Hiroshi Tomita
HYHiromu Yawo
Hiromu Yawo
A light signal is converted into an electrical one in a single molecule named channelrhodopsin, one of the archaea-type rhodopsins in unicellular green algae. Although highly homologous, two molecules of this family, channelrhodopsin-1 (ChR1) and -2 (ChR2), are distinct in photocurrent properties such as the wavelength sensitivity, desensitization, and turning-on and -off kinetics. However, the structures regulating these properties have not been completely identified. Photocurrents were analyzed for several chimera molecules made by replacing N-terminal segments of ChR2 with the homologous counterparts of ChR1. We found that the wavelength sensitivity of the photocurrent was red-shifted with negligible desensitization and slowed turning-on and -off kinetics when replacement was made with the segment containing the fifth transmembrane helix of ChR1. Therefore, this segment is involved in the determination of photocurrent properties, the wavelength sensitivity, and the kinetics characterizing ChR1 and ChR2. Eight amino acid residues differentiating this segment were exchanged one-by-one, and the photocurrent properties of each targeted mutant ChR2 were further analyzed. Among them, position Tyr(226)(ChR1)/Asn(187)(ChR2) is one of the molecular determinants involved in the wavelength sensitivity, desensitization, and turning-on and -off kinetics. It is suggested that these amino acid residues directly or indirectly interact with the chromophore as well as with the protein structure determining the photocurrent kinetics. Some of the chimera channelrhodopsins are suggested to have several advantages over the wild-type ChR2 in the introduction of light-induced membrane depolarization for the purpose of artificial stimulation of neurons in vivo and visual prosthesis for photoreceptor degeneration.

1 August 2007 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
Hiroshi TomitaHiroshi Tomita
Hiroshi Tomita
ESEriko Sugano
Eriko Sugano
HYHiromu Yawo
Hiromu Yawo
TIToru Ishizuka
Toru Ishizuka
HIHitomi Isago
Hitomi Isago
MTMakoto Tamai
Makoto Tamai
Purpose. To investigate whether the channelopsin-2 (Chop2) gene would restore visual responses in 10-month-old dystrophic Royal College of Surgeons (aged RCS; rdy/rdy) rats, the authors transferred the Chop2 gene into the retinal cells of aged RCS rats using the adenoassociated virus (AAV) vector.

1 March 2010 in Experimental Eye Research
Verified
Journal Article
Closed access
Hiroshi TomitaHiroshi Tomita
Hiroshi Tomita
ESEriko Sugano
Eriko Sugano
HIHitomi Isago
Hitomi Isago
THTeru Hiroi
Teru Hiroi
ZWZhuo Wang
Zhuo Wang
MTMakoto Tamai
Makoto Tamai

10 November 2015 in Scientific Reports
Verified
Journal Article
Open access
SHShoko Hososhima
Shoko Hososhima
HYHideya Yuasa
Hideya Yuasa
TIToru Ishizuka
Toru Ishizuka
MHMohammad Razuanul Hoque
Mohammad Razuanul Hoque
TYTakayuki Yamashita
Takayuki Yamashita
HYHiromu Yawo
Hiromu Yawo
Non-invasive remote control technologies designed to manipulate neural functions have been long-awaited for the comprehensive and quantitative understanding of neuronal network in the brain as well as for the therapy of neurological disorders. Recently, it has become possible for the neuronal activity to be optically manipulated using biological photo-reactive molecules such as channelrhodopsin (ChR)-2. However, ChR2 and its relatives are mostly reactive to visible light, which does not effectively penetrate through biological tissues. In contrast, near-infrared (NIR) light (650–1450 nm) penetrates deep into the tissues because biological systems are almost transparent to light within this so-called ‘imaging window’. Here we used lanthanide nanoparticles (LNPs), composed of rare-earth elements, as luminous bodies to activate ChRs since they absorb low-energy NIR light to emit high-energy visible light (up-conversion). Here, we created a new type of optogenetic system which consists of the donor LNPs and the acceptor ChRs. The NIR laser irradiation emitted visible light from LNPs, then induced the photo-reactive responses in the near-by cells that expressed ChRs. However, there remains room for large improvements in the energy efficiency of the LNP-ChR system.